| TOP2A-1-E | DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3300 | 0.40 | Binding ≤ 10μM | 
            
            | KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 200 | 0.49 | Functional ≤ 10μM | 
            
            | Z100501-1-O | Lu1 (Lung Carcinoma Cells) (cluster #1 Of 2), Other | Other | 80 | 0.52 | Functional ≤ 10μM | 
            
            | Z103204-1-O | A427 (cluster #1 Of 4), Other | Other | 890 | 0.45 | Functional ≤ 10μM | 
            
            | Z103205-3-O | A431 (cluster #3 Of 4), Other | Other | 470 | 0.47 | Functional ≤ 10μM | 
            
            | Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 501 | 0.46 | Functional ≤ 10μM | 
            
            | Z50426-9-O | Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other | Other | 73 | 0.53 | Functional ≤ 10μM | 
            
            | Z80008-2-O | 5637 (Epithelial Bladder Carcinoma Cells) (cluster #2 Of 3), Other | Other | 890 | 0.45 | Functional ≤ 10μM | 
            
            | Z80036-2-O | BaF3 (IL-3-dependent Pro-B-cells) (cluster #2 Of 3), Other | Other | 200 | 0.49 | Functional ≤ 10μM | 
            
            | Z80145-1-O | H69 (cluster #1 Of 4), Other | Other | 1800 | 0.42 | Functional ≤ 10μM | 
            
            | Z80156-10-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #10 Of 12), Other | Other | 660 | 0.46 | Functional ≤ 10μM | 
            
            | Z80164-3-O | HT-1080 (Fibrosarcoma Cells) (cluster #3 Of 6), Other | Other | 4300 | 0.40 | Functional ≤ 10μM | 
            
            | Z80186-10-O | K562 (Erythroleukemia Cells) (cluster #10 Of 11), Other | Other | 380 | 0.47 | Functional ≤ 10μM | 
            
            | Z80193-4-O | L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 12), Other | Other | 500 | 0.46 | Functional ≤ 10μM | 
            
            | Z80224-5-O | MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other | Other | 430 | 0.47 | Functional ≤ 10μM | 
            
            | Z80322-1-O | NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other | Other | 200 | 0.49 | Functional ≤ 10μM | 
            
            | Z80509-1-O | SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other | Other | 2000 | 0.42 | Functional ≤ 10μM | 
            
            | Z80583-1-O | Vero (Kidney Cells) (cluster #1 Of 7), Other | Other | 800 | 0.45 | Functional ≤ 10μM | 
            
            | Z80682-7-O | A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other | Other | 470 | 0.47 | Functional ≤ 10μM | 
            
            | Z80784-1-O | Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other | Other | 2300 | 0.42 | Functional ≤ 10μM | 
            
            | Z80928-5-O | HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other | Other | 410 | 0.47 | Functional ≤ 10μM | 
            
            | Z81024-8-O | NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other | Other | 510 | 0.46 | Functional ≤ 10μM | 
            
            | Z81115-3-O | KB  (Squamous Cell Carcinoma) (cluster #3 Of 6), Other | Other | 812 | 0.45 | Functional ≤ 10μM | 
            
            | Z81115-3-O | KB  (Squamous Cell Carcinoma) (cluster #3 Of 6), Other | Other | 1780 | 0.42 | Functional ≤ 10μM | 
            
            | Z81170-5-O | LNCaP (Prostate Carcinoma) (cluster #5 Of 5), Other | Other | 3250 | 0.40 | Functional ≤ 10μM | 
            
            | Z81247-2-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other | Other | 310 | 0.48 | Functional ≤ 10μM | 
            
            | Z81252-10-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other | Other | 2300 | 0.42 | Functional ≤ 10μM | 
            
            | Z81277-1-O | NCI-N417 (cluster #1 Of 2), Other | Other | 870 | 0.45 | Functional ≤ 10μM | 
            
            | Z80156-2-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 4), Other | Other | 2600 | 0.41 | ADME/T ≤ 10μM | 
            
            | Z80164-1-O | HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 1), Other | Other | 5010 | 0.39 | ADME/T ≤ 10μM | 
            
            | Z80193-2-O | L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 4), Other | Other | 190 | 0.50 | ADME/T ≤ 10μM | 
            
            | Z80583-3-O | Vero (Kidney Cells) (cluster #3 Of 3), Other | Other | 3820 | 0.40 | ADME/T ≤ 10μM | 
            
            | Z80583-3-O | Vero (Kidney Cells) (cluster #3 Of 3), Other | Other | 5500 | 0.39 | ADME/T ≤ 10μM | 
            
            | Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 3), Other | Other | 2070 | 0.42 | ADME/T ≤ 10μM | 
            
            | Z80784-1-O | Col2 (Colon Carcinoma Cells) (cluster #1 Of 1), Other | Other | 1820 | 0.42 | ADME/T ≤ 10μM | 
            
            | Z80951-1-O | NIH3T3 (Fibroblasts) (cluster #1 Of 1), Other | Other | 3 | 0.63 | ADME/T ≤ 10μM | 
            
            | Z81057-4-O | HUVEC (Umbilical Vein Endothelial Cells) (cluster #4 Of 5), Other | Other | 370 | 0.47 | ADME/T ≤ 10μM | 
            
            | Z81115-1-O | KB  (Squamous Cell Carcinoma) (cluster #1 Of 3), Other | Other | 5300 | 0.39 | ADME/T ≤ 10μM |